Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Aptevo Research and Development LLC”

12 pharma patents match "Aptevo Research and Development LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 12
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 12 pharmaceutical patents matching "Aptevo Research and Development LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

12 results for “Aptevo Research and Development LLC” · 30,257 patents in full index Clear search

  1. US 11939392

    CD123 binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  2. US 11725060

    Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods

    Aptevo Research and Development LLC · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  3. US 11352426

    CD3 binding polypeptides

    Aptevo Research and Development LLC · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted
  4. US 11312786

    Oncofetal antigen binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Apr 26, 2022 · Expires Apr 21, 2042

    granted
  5. US 11242400

    CD123 binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Feb 8, 2022 · Expires Feb 3, 2042

    granted
  6. US 10676533

    Methods of treatment of CD123 overexpressing disorders

    Aptevo Research and Development LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  7. US 10307481

    CD37 immunotherapeutics and uses thereof

    Aptevo Research and Development LLC · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  8. US 10239949

    Oncofetal antigen binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted
  9. US 10202452

    CD3 binding polypeptides

    Aptevo Research and Development LLC · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted
  10. US 10143748

    B-cell reduction using CD37-specific and CD20-specific binding molecules

    Aptevo Research and Development LLC · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted
  11. US 9782478

    Prostate-specific membrane antigen binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  12. US 9493564

    CD86 antagonist multi-target binding proteins

    Aptevo Research and Development LLC · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted